1 March 2023 false No description of principal activity Taxfiler 2024.5 06127017business:PrivateLimitedCompanyLtd2023-03-012024-02-29 061270172023-02-28 061270172023-03-012024-02-29 06127017business:AuditExempt-NoAccountantsReport2023-03-012024-02-29 06127017business:FilletedAccounts2023-03-012024-02-29 061270172024-02-29 06127017business:Director12023-03-012024-02-29 06127017business:RegisteredOffice2023-03-012024-02-29 061270172023-02-28 06127017core:WithinOneYear2024-02-29 06127017core:WithinOneYear2023-02-28 06127017core:ShareCapitalcore:PreviouslyStatedAmount2024-02-29 06127017core:ShareCapitalcore:PreviouslyStatedAmount2023-02-28 06127017core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-02-29 06127017core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-02-28 06127017core:PreviouslyStatedAmount2024-02-29 06127017core:PreviouslyStatedAmount2023-02-28 06127017business:SmallEntities2023-03-012024-02-29 06127017countries:EnglandWales2023-03-012024-02-29 06127017core:ComputerEquipment2023-02-28 06127017core:ComputerEquipment2024-02-29 06127017core:ComputerEquipment2023-03-012024-02-29 061270172022-03-012023-02-28 iso4217:GBP xbrli:pure
Company Registration No. 06127017 (England and Wales)
PHARMAWAVE LTD Unaudited accounts for the year ended 29 February 2024
PHARMAWAVE LTD Unaudited accounts Contents
Page
- 2 -
PHARMAWAVE LTD Company Information for the year ended 29 February 2024
Director
Paolo Bessieres
Company Number
06127017 (England and Wales)
Registered Office
Office Me-123 1 St Katharine's Way LONDON E1W 1YL ENGLAND
- 3 -
PHARMAWAVE LTD Statement of financial position as at 29 February 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
1,007 
1,510 
Current assets
Inventories
14,339 
12,858 
Cash at bank and in hand
286,657 
295,462 
300,996 
308,320 
Creditors: amounts falling due within one year
(4,661)
(4,661)
Net current assets
296,335 
303,659 
Net assets
297,342 
305,169 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
297,242 
305,069 
Shareholders' funds
297,342 
305,169 
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 30 September 2024 and were signed on its behalf by
Paolo Bessieres Director Company Registration No. 06127017
- 4 -
PHARMAWAVE LTD Notes to the Accounts for the year ended 29 February 2024
1
Statutory information
PHARMAWAVE LTD is a private company, limited by shares, registered in England and Wales, registration number 06127017. The registered office is Office Me-123, 1 St Katharine's Way, LONDON, E1W 1YL, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 March 2023
2,013 
At 29 February 2024
2,013 
Depreciation
At 1 March 2023
503 
Charge for the year
503 
At 29 February 2024
1,006 
Net book value
At 29 February 2024
1,007 
At 28 February 2023
1,510 
5
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Loans from directors
2,206 
2,206 
Accruals
2,455 
2,455 
4,661 
4,661 
6
Average number of employees
During the year the average number of employees was 0 (2023: 0).
- 5 -